Frequency of MIC Antibody in Rejected Renal Transplant Patients without HLA Antibody

Human Immunology

Volumn 67, Issue 3, 2006, Pages 223-229

  Mizutani, Kazuo ^a   Terasaki, Paul I ^a   Shih, Remi N J ^b   Pei, Rui ^b   Ozawa, Miyuki ^b   Lee, Jarhow ^b  

^a TERASAKI FOUNDATION LABORATORY   (United States)

^b One Lambda Inc   (United States)

Author keywords

HLA; kidney transplant; MICA; MICB; rejection

Indexed keywords

ALLOANTIBODY; HLA ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED B; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; IMMUNIZATION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; SERUM;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 33646346132     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.02.007     Document Type: Article

References (17)

1. Terasaki P.I. Humoral theory of transplantation. Am J Transplant 3 (2003) 665
2. Harmer A.W., Koffman C.G., Heads A.J., and Vaughan R.W. Sensitization to HLA antigens occurs in 95% of primary renal transplant rejections. Transplant Proc 27 (1995) 666
3. Lee P.C., Terasaki P.I., Takemoto S.K., Lee P.H., Hung C.J., Chen Y.L., Tsai A., and Lei H.Y. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 74 8 (2002) 1192
4. El-Awar N., Terasaki P.I., Lazda V., Nikaein A., Manning C., and Armold A.N. Almost all patients who are waiting for a regraft of a kidney transplant have anti HLA antibodies. Transplant Proc 34 (2002) 2531
5. Worthington J.E., Martin S., Dyer P.A., and Jahson R.W.G. An association between posttransplant antibody production and renal transplant rejection. Transplant Proc 33 (2001) 475
6. Zou Y., Mirbaha F., Lazaro A., Zhang Y., Lavingia B., and Stastny P. MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies. Hum Immunol 63 (2002) 30
7. Hankey K.G., Drachenberg C.B., Papadimitriou J.C., Klassen D.K., Philosophe B., Bartlett S.T., Groh V., Spies T., and Mann D.L. MIC expression in renal and pancreatic allografts. Transplantation 73 (2002) 304
8. Zwirner N.W., Marcos C.Y., Mirbaha F., Zou Y., and Stastny P. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 61 (2000) 917
9. Pei R., Wang G., Tarsitani C., Chen T., Takemura S., Liu A., and Lee J. Hum Immunol 59 (1998) 133
10. Crespo M., Pascual M., Tolkoff-Rubin N., Mauiyyedi S., Collins A.B., Fitzpatrick D., Farrell M.L., Wiliams W.W., Delmonico F.L., Cosimi A.B., Colvin R.B., and Saidman S.L. Acute humoral rejection in renal allograft recipients. I. Incidence, serology and clinical characteristics. Transplantation 71 (2001) 652
11. Terasaki P.I., and Ozawa M. Predicting kidney graft failure by HLA antibodies. a prospective trial. Am J Transplant 4 (2004) 438
12. Zhang Q., Liang L.W., Gjertson D.W., Lassman C., Wilkinson A.H., Kendrick E., Pham P.T.T., Danovitch G.M., Gritsch H.A., and Reed E.F. Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction. Transplantation 79 (2005) 591
13. Zwirner N.W., Fernandez-Vina M.A., and Stastny P. MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics 47 (1998) 139
14. Zwirner N.W., Dole K., and Stastny P. Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum Immunol 60 (1999) 323
15. Sumitran-Holgersson S.W.H., Wilczek H.E., Holgersson J., and Soderstrom K. Identification of the nonclassical HLA molecules. MICA, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 74 (2002) 268
16. Faulk W., Rose M., Meroni P.L., Papa N.D., Torry R.J., Labarrere C.A., Busing K., Crisp S.J., Dunn M.J., and Nelson D.R. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts. Hum Immunol 60 (1999) 826
17. Sumitran-Karuppan S., Tyden G., Reinholt F., Berg U., and Moller E. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 5 (1997) 321